Saturday - April 19, 2025
FDA Withdraws Approval of 18 Drug Applications Including GE HealthCare, Pfizer, AbbVie, and Others
April 09, 2025
WASHINGTON, April 9 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration announced the formal withdrawal of approval for 18 new drug applications (NDAs) from several pharmaceutical manufacturers, including GE HealthCare, Pfizer Inc., AbbVie Inc., Janssen Pharmaceuticals, and others. The move comes after the companies voluntarily informed the agency that the drug products are no longer being marketed and requested the termination of their applications. The with . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products